Fluconazole 100mg Tablets
Overview
What is this medicine?
How to Use This Medicine
To use this medication correctly, follow your doctor's instructions and read all the information provided. Take your medication as directed, with or without food. Continue taking it even if you feel well, unless your doctor or healthcare provider tells you to stop.
Storing and Disposing of Your Medication
Store your medication at room temperature in a dry place, avoiding the bathroom. Keep all medications in a safe location, out of the reach of children and pets. Dispose of unused or expired medications properly. Do not flush them down the toilet or pour them down the drain unless instructed to do so. If you have questions about disposal, consult your pharmacist. You may also have access to drug take-back programs in your area.
Missing a Dose
If you miss a dose, take it as soon as you remember. However, if it's close to the time for your next dose, skip the missed dose and resume your regular schedule. Do not take two doses at the same time or take extra doses to make up for the missed one.
Lifestyle & Tips
- Take the medication exactly as prescribed by your doctor, even if your symptoms improve. Do not stop early unless advised by your doctor.
- For vaginal yeast infections, a single dose is often sufficient. For other infections, you may need to take it for weeks or months.
- Maintain good hygiene to prevent recurrence of fungal infections.
- Stay hydrated unless otherwise advised by your doctor.
- Avoid alcohol consumption, especially during prolonged therapy, as it can increase the risk of liver problems.
Available Forms & Alternatives
Dosing & Administration
Adult Dosing
Condition-Specific Dosing:
Pediatric Dosing
Dose Adjustments
Renal Impairment:
Hepatic Impairment:
Pharmacology
Mechanism of Action
Pharmacokinetics
Absorption:
Distribution:
Elimination:
Pharmacodynamics
Safety & Warnings
Side Effects
Although rare, some people may experience severe and potentially life-threatening side effects while taking this medication. If you notice any of the following symptoms, contact your doctor immediately or seek emergency medical attention:
Signs of an allergic reaction, such as:
+ Rash
+ Hives
+ Itching
+ Red, swollen, blistered, or peeling skin with or without fever
+ Wheezing
+ Tightness in the chest or throat
+ Trouble breathing, swallowing, or talking
+ Unusual hoarseness
+ Swelling of the mouth, face, lips, tongue, or throat
Signs of liver problems, including:
+ Dark urine
+ Tiredness
+ Decreased appetite
+ Upset stomach or stomach pain
+ Light-colored stools
+ Vomiting
+ Yellow skin or eyes
Signs of a weak adrenal gland, such as:
+ Severe upset stomach or vomiting
+ Severe dizziness or fainting
+ Muscle weakness
+ Feeling very tired
+ Mood changes
+ Decreased appetite
+ Weight loss
Seizures
A type of severe abnormal heartbeat (prolonged QT interval), which can increase the risk of another type of abnormal heartbeat (torsades de pointes). This is more likely to occur in people with other serious health problems or those taking other medications that can affect heart rhythm. If you experience a fast or abnormal heartbeat, or if you faint, contact your doctor right away.
Other Possible Side Effects
Like all medications, this drug can cause side effects. While many people may not experience any side effects or only minor ones, it's essential to discuss any concerns with your doctor. If you experience any of the following side effects, or if they bother you or persist, contact your doctor:
Dizziness or headache
Stomach pain or diarrhea
Upset stomach or vomiting
* Change in taste
This is not an exhaustive list of possible side effects. If you have questions or concerns about side effects, consult your doctor. You can also report side effects to the FDA at 1-800-332-1088 or online at https://www.fda.gov/medwatch.
Seek Immediate Medical Attention If You Experience:
- Signs of liver problems: unusual tiredness, yellowing of the skin or eyes (jaundice), dark urine, pale stools, nausea, vomiting, or stomach pain.
- Signs of a severe skin reaction: rash, blistering, peeling skin, fever, or flu-like symptoms.
- Signs of an allergic reaction: rash, itching, hives, swelling of the face, lips, tongue, or throat, difficulty breathing.
- Signs of heart problems: dizziness, lightheadedness, fainting, or fast/irregular heartbeat.
- Unusual bruising or bleeding.
Before Using This Medicine
It is essential to inform your doctor about the following:
Any allergies you have, including allergies to this medication, its components, or other substances, such as foods or drugs. Be sure to describe the allergic reaction you experienced, including any symptoms that occurred.
If you are currently taking any of the following medications: Abrocitinib, astemizole, cisapride, erythromycin, lemborexant, olaparib, pimozide, quinidine, terfenadine, or voriconazole.
If you are pregnant or think you may be pregnant. You will need to discuss the potential risks and benefits of this medication with your doctor to determine if it is suitable for you.
Please note that this is not an exhaustive list of all possible interactions between this medication and other substances. Therefore, it is crucial to:
Inform your doctor and pharmacist about all the medications you are taking, including prescription and over-the-counter drugs, natural products, and vitamins.
Share information about your health problems, as this will help your doctor and pharmacist assess whether it is safe for you to take this medication.
Never start, stop, or change the dose of any medication without first consulting your doctor to ensure your safety.
Precautions & Cautions
Until you are aware of how this drug affects you, avoid operating a vehicle or engaging in any activities that require your full attention.
Do not exceed the prescribed duration of treatment, as this may increase the risk of a secondary infection.
Regular blood tests will be necessary, as directed by your doctor. Be sure to discuss any concerns or questions with your doctor.
Before consuming alcohol, consult with your doctor to understand any potential risks or interactions.
Be aware that severe skin reactions, including potentially life-threatening rashes, have been associated with this medication, particularly in individuals with pre-existing health conditions. If you experience any unusual skin symptoms, promptly discuss them with your doctor.
Although rare, severe liver problems, sometimes fatal, have occurred in patients taking this drug, often in those with underlying health issues. If you have any concerns, consult your doctor.
In some cases, a severe and potentially life-threatening reaction may occur, characterized by symptoms such as fever, rash, swollen glands, and organ dysfunction (affecting the liver, kidneys, blood, heart, muscles, joints, or lungs). If you have any questions or concerns, discuss them with your doctor.
If you are 65 years or older, exercise caution when taking this medication, as you may be more susceptible to side effects.
For women of childbearing potential, discuss the need for birth control with your doctor to prevent pregnancy during treatment and for a period after the last dose, as this medication may harm the unborn baby.
If you become pregnant or suspect you are pregnant while taking this medication, immediately contact your doctor.
If you are breastfeeding, inform your doctor to discuss any potential risks to your baby.
Overdose Information
Overdose Symptoms:
- Hallucinations
- Paranoid behavior
- Seizures
- Nausea
- Vomiting
- Diarrhea
What to Do:
Seek immediate medical attention or call a Poison Control Center (1-800-222-1222). Treatment may include symptomatic and supportive measures, and gastric lavage if appropriate.
Drug Interactions
Contraindicated Interactions
- Terfenadine (at fluconazole doses âĨ400 mg/day)
- Cisapride
- Pimozide
- Quinidine
- Erythromycin (due to increased risk of cardiotoxicity)
Major Interactions
- Amiodarone (increased risk of QT prolongation and Torsades de Pointes)
- Warfarin (increased prothrombin time/INR, bleeding risk)
- Phenytoin (increased phenytoin levels)
- Sulfonylureas (e.g., glipizide, glyburide, tolbutamide - increased hypoglycemia risk)
- Rifampin (decreased fluconazole levels)
- Hydrochlorothiazide (increased fluconazole levels)
- Cyclosporine (increased cyclosporine levels)
- Tacrolimus (increased tacrolimus levels)
- Sirolimus (increased sirolimus levels)
- Theophylline (increased theophylline levels)
- Benzodiazepines (e.g., midazolam, triazolam - increased benzodiazepine levels)
- Statins (e.g., atorvastatin, simvastatin - increased statin levels, rhabdomyolysis risk)
- Oral contraceptives (altered hormone levels, though clinical significance often minimal)
- Voriconazole (mutual inhibition, increased levels of both drugs)
- Fentanyl (increased fentanyl levels, respiratory depression risk)
- Methadone (increased methadone levels, QT prolongation risk)
- Tofacitinib (increased tofacitinib levels)
- Ivacaftor (increased ivacaftor levels)
Moderate Interactions
- NSAIDs (e.g., celecoxib, ibuprofen, naproxen - increased NSAID levels)
- Amitriptyline (increased amitriptyline levels)
- Nortriptyline (increased nortriptyline levels)
- Losartan (decreased losartan active metabolite)
- Carbamazepine (increased carbamazepine levels)
- Vincristine (increased vincristine levels, neurotoxicity risk)
- Vitamin A (increased vitamin A levels, CNS effects)
- Zidovudine (increased zidovudine levels)
- Saquinavir (increased saquinavir levels)
- Alfentanil (increased alfentanil levels)
- Amprenavir (decreased fluconazole levels)
- Indinavir (increased indinavir levels)
- Ritonavir (increased fluconazole levels)
- Everolimus (increased everolimus levels)
Minor Interactions
- Cimetidine (minor decrease in fluconazole absorption)
- Antacids (no significant interaction)
Monitoring
Baseline Monitoring
Rationale: Fluconazole can cause hepatotoxicity, ranging from transient elevations to rare cases of hepatic necrosis.
Timing: Prior to initiation of therapy, especially for prolonged courses or in patients with pre-existing liver disease.
Rationale: Fluconazole is primarily renally eliminated, and dose adjustments are necessary in renal impairment.
Timing: Prior to initiation of therapy.
Rationale: To assess baseline risk for QT prolongation, especially in patients with cardiac conditions or on other QT-prolonging drugs.
Timing: Prior to initiation of therapy, particularly for high-dose or prolonged therapy.
Routine Monitoring
Frequency: Weekly to monthly for prolonged therapy, or as clinically indicated.
Target: Within normal limits or stable for patient's baseline.
Action Threshold: Discontinue fluconazole if signs/symptoms of liver disease develop, or if LFTs significantly elevate (e.g., >3-5x ULN) and are persistent or progressive.
Frequency: Periodically for prolonged therapy, or as clinically indicated.
Target: Stable, within patient's baseline.
Action Threshold: Adjust dose if significant decline in renal function.
Frequency: Periodically for prolonged therapy, or if patient is at risk for electrolyte disturbances.
Target: Within normal limits.
Action Threshold: Correct electrolyte abnormalities to minimize QT prolongation risk.
Frequency: Daily to weekly, depending on severity of infection.
Target: Resolution of signs and symptoms of fungal infection.
Action Threshold: Re-evaluate diagnosis and treatment if no clinical improvement or worsening of infection.
Frequency: Frequently (e.g., 2-3 times per week initially, then weekly) when co-administered.
Target: Therapeutic range for indication.
Action Threshold: Adjust warfarin dose to maintain target INR.
Symptom Monitoring
- Rash (especially severe cutaneous reactions like SJS/TEN)
- Jaundice or yellowing of skin/eyes
- Dark urine
- Pale stools
- Unusual fatigue or weakness
- Nausea, vomiting, or abdominal pain (signs of liver injury)
- Signs of allergic reaction (swelling of face, lips, tongue, throat, difficulty breathing)
- Dizziness, lightheadedness, fainting (signs of QT prolongation/arrhythmia)
- Changes in mental status or seizures (rare CNS effects)
- Muscle pain or weakness (if co-administered with statins)
Special Patient Groups
Pregnancy
Fluconazole is generally considered Category D for pregnancy, meaning there is positive evidence of human fetal risk. However, the risk appears to be dose- and duration-dependent. Single 150 mg doses for vaginal candidiasis are generally considered low risk, while high doses (400-800 mg/day) for prolonged periods (e.g., >14 days) have been associated with a pattern of birth defects (e.g., brachycephaly, abnormal facies, cleft palate, femoral bowing, rib-forearm synostosis, congenital heart disease) in a few cases. Use during pregnancy should be avoided unless the potential benefit justifies the potential risk to the fetus.
Trimester-Specific Risks:
Lactation
Fluconazole is excreted into breast milk. The relative infant dose (RID) is estimated to be 10-20%. While generally considered compatible with breastfeeding for single low doses, caution is advised for high-dose or prolonged therapy due to potential for infant exposure and theoretical risks of hepatotoxicity or cardiac effects. Monitor breastfed infants for adverse effects.
Pediatric Use
Fluconazole is approved for use in pediatric patients for various fungal infections, including oropharyngeal and esophageal candidiasis, systemic candidiasis, and cryptococcal meningitis. Dosing is weight-based and varies by age and indication. Neonates require specific dosing adjustments due to immature renal function. Close monitoring for adverse effects is important.
Geriatric Use
No overall differences in safety or effectiveness were observed between elderly and younger patients, but greater sensitivity of some older individuals cannot be ruled out. Dose adjustment may be necessary based on renal function, which is often decreased in elderly patients. Monitor for drug interactions and adverse effects more closely due to polypharmacy and comorbidities.
Clinical Information
Clinical Pearls
- Fluconazole has excellent oral bioavailability, allowing for a switch from IV to oral therapy once the patient is stable.
- The long half-life of fluconazole allows for once-daily dosing for most indications and single-dose therapy for vaginal candidiasis.
- Be vigilant for drug interactions, especially with drugs metabolized by CYP2C9, CYP2C19, and CYP3A4, and drugs that prolong the QT interval.
- Monitor liver function tests, especially during prolonged therapy, and discontinue if signs of hepatotoxicity occur.
- For patients with renal impairment, dose adjustment is crucial to prevent accumulation and toxicity.
- While generally well-tolerated, advise patients to report any signs of severe skin reactions or allergic reactions immediately.
Alternative Therapies
- Other Azole Antifungals (e.g., Itraconazole, Voriconazole, Posaconazole, Isavuconazole)
- Echinocandins (e.g., Caspofungin, Micafungin, Anidulafungin) - for invasive candidiasis, especially C. glabrata or C. krusei
- Polyenes (e.g., Amphotericin B formulations, Nystatin)
- Flucytosine (often used in combination with amphotericin B for cryptococcal infections)